Anti-ERMN monoclonal antibody

Pre-made anti-ERMN monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ERMN/ERMN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2479-Ab-1/ GM-Tg-hg-IP2479-Ab-2Anti-Human ERMN monoclonal antibodyHuman
GM-Tg-rg-IP2479-Ab-1/ GM-Tg-rg-IP2479-Ab-2Anti-Rat ERMN monoclonal antibodyRat
GM-Tg-mg-IP2479-Ab-1/ GM-Tg-mg-IP2479-Ab-2Anti-Mouse ERMN monoclonal antibodyMouse
GM-Tg-cynog-IP2479-Ab-1/ GM-Tg-cynog-IP2479-Ab-2Anti-Cynomolgus/ Rhesus macaque ERMN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2479-Ab-1/ GM-Tg-felg-IP2479-Ab-2Anti-Feline ERMN monoclonal antibodyFeline
GM-Tg-cang-IP2479-Ab-1/ GM-Tg-cang-IP2479-Ab-2Anti-Canine ERMN monoclonal antibodyCanine
GM-Tg-bovg-IP2479-Ab-1/ GM-Tg-bovg-IP2479-Ab-2Anti-Bovine ERMN monoclonal antibodyBovine
GM-Tg-equg-IP2479-Ab-1/ GM-Tg-equg-IP2479-Ab-2Anti-Equine ERMN monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2479-Ab-1/ GM-Tg-hg-IP2479-Ab-2; GM-Tg-rg-IP2479-Ab-1/ GM-Tg-rg-IP2479-Ab-2;
GM-Tg-mg-IP2479-Ab-1/ GM-Tg-mg-IP2479-Ab-2; GM-Tg-cynog-IP2479-Ab-1/ GM-Tg-cynog-IP2479-Ab-2;
GM-Tg-felg-IP2479-Ab-1/ GM-Tg-felg-IP2479-Ab-2; GM-Tg-cang-IP2479-Ab-1/ GM-Tg-cang-IP2479-Ab-2;
GM-Tg-bovg-IP2479-Ab-1/ GM-Tg-bovg-IP2479-Ab-2; GM-Tg-equg-IP2479-Ab-1/ GM-Tg-equg-IP2479-Ab-2
Products NameAnti-ERMN monoclonal antibody
Formatmab
Target NameERMN
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ERMN monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2479-Ag-1Recombinant multi-species ERMIN/ ERMN/ JN protein
    ORF Viral VectorpGMLP003133human ERMN Lentivirus plasmid
    ORF Viral VectorvGMLP003133human ERMN Lentivirus particle
    ORF Viral VectorpGMLV000056mouse Ermn Lentivirus plasmid
    ORF Viral VectorvGMLV000056mouse Ermn Lentivirus particle


    Target information

    Target IDGM-IP2479
    Target NameERMN
    Gene ID57471,77767,295619,697560,607626,101095358,617274,100059459
    Gene Symbol and SynonymsA330104H05Rik,ermin,ERMN,JN,juxtanodin,KIAA1189,mKIAA1189,RGD1308367
    Uniprot AccessionQ8TAM6,Q5RJL0,Q3ZBR9
    Uniprot Entry NameERMIN_HUMAN,ERMIN_RAT,ERMIN_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000136541
    Target ClassificationN/A

    The target: ERMN, gene name: ERMN, also named as JN, KIAA1189. Predicted to enable actin filament binding activity. Involved in actin filament organization; regulation of cell projection organization; and regulation of cell shape. Located in cell cortex; internode region of axon; and paranode region of axon. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.